We are live on ! Find out more
EHWM

Eads & Heald Wealth Management Portfolio holdings

AUM $204M
1-Year Est. Return 28.27%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+28.27%
3 Year Est. Return
+84.36%
5 Year Est. Return
+119.71%
10 Year Est. Return
+418.2%
AUM
$147M
AUM Growth
+$1.46M
Cap. Flow
+$183K
Cap. Flow %
0.12%
Top 10 Hldgs %
14.79%
Holding
136
New
6
Increased
51
Reduced
68
Closed
4

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$751K
2
GILD icon
Gilead Sciences
GILD
+$353K
3
BBWI icon
Bath & Body Works
BBWI
+$296K
4
TOL icon
Toll Brothers
TOL
+$245K
5
EFX icon
Equifax
EFX
+$217K

Sector Composition

Rank Sector Weight
1 Healthcare 16.06%
2 Industrials 15.91%
3 Technology 13.91%
4 Consumer Staples 12.85%
5 Consumer Discretionary 11.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EW icon
101
Edwards Lifesciences
EW
$49.4B
$469K 0.32%
15,021
+654
+5% +$21.2K
UN
102
DELISTED
Unilever NV New York Registry Shares
UN
$467K 0.32%
11,364
-166
-1% -$6.87K
FDX icon
103
FedEx
FDX
$73.1B
$458K 0.31%
2,459
-88
-3% -$16.1K
MKC icon
104
McCormick & Company Non-Voting
MKC
$13.8B
$452K 0.31%
9,680
KMB icon
105
Kimberly-Clark
KMB
$36.3B
$446K 0.3%
3,904
+2,069
+113% +$240K
PFG icon
106
Principal Financial Group
PFG
$24.1B
$436K 0.3%
7,544
+514
+7% +$28.8K
VAL
107
DELISTED
Valspar
VAL
$427K 0.29%
4,120
-115
-3% -$11.9K
MAR icon
108
Marriott International
MAR
$98.8B
$420K 0.29%
5,081
ADI icon
109
Analog Devices
ADI
$179B
$410K 0.28%
5,646
+225
+4% +$15.3K
VLO icon
110
Valero Energy
VLO
$91.8B
$410K 0.28%
6,008
+840
+16% +$51.7K
DE icon
111
Deere & Co
DE
$160B
$405K 0.28%
3,933
-187
-5% -$17.6K
NVO
112
Novo Nordisk
NVO
$209B
$378K 0.26%
21,080
-2,120
-9% -$38.4K
FDS icon
113
Factset
FDS
$9.28B
$362K 0.25%
2,218
APC
114
DELISTED
Anadarko Petroleum
APC
$344K 0.23%
4,932
-50
-1% -$3.25K
BIIB icon
115
Biogen
BIIB
$30B
$343K 0.23%
1,211
-274
-18% -$81.2K
AGN
116
DELISTED
Allergan plc
AGN
$322K 0.22%
1,531
-3,623
-70% -$751K
VMC icon
117
Vulcan Materials
VMC
$35.2B
$282K 0.19%
+2,250
New +$272K
GSK icon
118
GSK
GSK
$104B
$264K 0.18%
5,479
-240
-4% -$11.9K
ITT icon
119
ITT
ITT
$17.3B
$262K 0.18%
6,804
-441
-6% -$16.6K
SRCL
120
DELISTED
Stericycle Inc
SRCL
$259K 0.18%
3,362
-2,639
-44% -$199K
DGX icon
121
Quest Diagnostics
DGX
$25.8B
$228K 0.16%
2,485
WDC icon
122
Western Digital
WDC
$188B
$213K 0.15%
4,156
-378
-8% -$17.4K
GM icon
123
General Motors
GM
$79.5B
$206K 0.14%
+5,925
New +$199K
HSY icon
124
Hershey
HSY
$35.6B
$203K 0.14%
+1,966
New +$194K
ORI icon
125
Old Republic International
ORI
$10.5B
$202K 0.14%
10,620
+135
+1% +$2.43K

Similar funds

Eads & Heald Wealth Management's Q4 2016 Portfolio in Review

As of Q4 2016, Eads & Heald Wealth Management held 136 positions worth $147M, up 1% from $145M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Eads & Heald Wealth Management's Q4 2016 filing shows 6 new, 51 increased, 68 reduced and 4 closed positions. Its largest new stake was Vulcan Materials: 2,250 shares worth $282K. The largest sale was Allergan plc, an estimated $751K.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.

  • Eads & Heald Wealth Management's largest Q4 2016 buy was Vulcan Materials: 2,250 shares worth $282K.
  • Eads & Heald Wealth Management added most to Meta Platforms (Facebook) in Q4 2016, an estimated $773K increase.
  • Eads & Heald Wealth Management's biggest Q4 2016 reduction was Allergan plc, cutting an estimated $751K.
  • Eads & Heald Wealth Management fully exited Gilead Sciences in Q4 2016, selling an estimated $353K.
  • Eads & Heald Wealth Management's ten largest holdings make up 15% of its $147M portfolio in Q4 2016.
  • Eads & Heald Wealth Management opened 6 new positions and closed 4 in Q4 2016.
  • Eads & Heald Wealth Management's portfolio value rose 1% quarter-over-quarter to $147M.

Based on Eads & Heald Wealth Management's 13F filing for Q4 2016, filed 13 Feb 2017.